Pestalozzi advises Biogen Idec on its USD 32.5 milliontakeover of Panima Pharmaceuticals AG
Biogen, a Biotech company with the leading portfolio of medicines to treat multiple sclerosis (MS) aquired Swiss Biotech company Panima. Pestalozzi advised on all aspects of the transaction.